Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionHilltop Holdings Inc.
Latest Disclosed Ownership6,089 shares
Latest Disclosed Value $ 2,142,161
Hilltop Holdings Inc. reports 77.21% increase in ownership of AMGN / Amgen Inc.

On May 14, 2026 - Hilltop Holdings Inc. filed a 13F-HR form disclosing ownership of 6,089 shares of Amgen Inc. (CH:AMGN) valued at $2,142,161 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,436 shares of Amgen Inc.. This represents a change in shares of 77.21% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMGEN COM 031162100 6,089 2,653 77.21 2,142 90.57 0.1927
2026-02-17 2025-12-31 13F Amgen COM 031162100 3,436 -26,088 -88.36 1,125 -86.51 0.0666
2025-11-14 2025-09-30 13F AMGEN COM 031162100 29,524 25,905 715.81 8,332 724.85 0.4407
2025-08-14 2025-06-30 13F AMGEN COM 031162100 3,619 -25,709 -87.66 1,010 -88.94 0.0647
2025-05-15 2025-03-31 13F AMGEN COM 031162100 29,328 -1,572 -5.09 9,137 13.45 0.5735
2025-02-14 2024-12-31 13F AMGEN COM 031162100 30,900 226 0.74 8,054 -18.52 0.5085
2024-11-14 2024-09-30 13F AMGEN COM 031162100 30,674 22,462 273.53 9,883 285.30 0.6312
2024-08-14 2024-06-30 13F AMGEN COM 031162100 8,212 478 6.18 2,566 16.70 0.2964
2024-05-15 2024-03-31 13F AMGEN COM 031162100 7,734 813 11.75 2,199 10.29 0.2270
2024-02-12 2023-12-31 13F AMGEN COM 031162100 6,921 2,397 52.98 1,993 64.03 0.2260
2023-11-14 2023-09-30 13F AMGEN COM 031162100 4,524 -3,364 -42.65 1,216 -30.61 0.1418
2023-08-14 2023-06-30 13F AMGEN COM 031162100 7,888 3,535 81.21 1,751 66.44 0.2130
2023-05-15 2023-03-31 13F AMGEN COM 031162100 4,353 -2,483 -36.32 1,052 -41.39 0.1382
2023-02-14 2022-12-31 13F AMGEN COM 031162100 6,836 87 1.29 1,795 18.01 0.2301
2022-11-14 2022-09-30 13F AMGEN COM 031162100 6,749 241 3.70 1,521 -3.92 0.2058
2022-08-15 2022-06-30 13F AMGEN COM 031162100 6,508 259 4.14 1,583 4.70 0.2096
2022-05-16 2022-03-31 13F AMGEN COM 031162100 6,249 -112 -1.76 1,512 5.66 0.1703
2022-02-14 2021-12-31 13F AMGEN COM 031162100 6,361 1,749 37.92 1,431 45.87 0.1487
2021-11-15 2021-09-30 13F AMGEN COM 031162100 4,612 122 2.72 981 -10.41 0.1075
2021-08-16 2021-06-30 13F AMGEN COM 031162100 4,490 -707 -13.60 1,095 -15.31 0.1234
2021-05-17 2021-03-31 13F AMGEN COM 031162100 5,197 -133 -2.50 1,293 5.55 0.1669
2021-02-16 2020-12-31 13F AMGEN COM 031162100 5,330 -156 -2.84 1,225 -12.19 0.1714
2020-11-16 2020-09-30 13F AMGEN COM 031162100 5,486 -219 -3.84 1,395 3.72 0.2366
2020-08-14 2020-06-30 13F AMGEN COM 031162100 5,705 -939 -14.13 1,345 -0.15 0.2484
2020-05-15 2020-03-31 13F AMGEN COM 031162100 6,644 2,049 44.59 1,347 21.68 0.3246
2020-02-14 2019-12-31 13F AMGEN COM 031162100 4,595 -1,133 -19.78 1,107 -0.09 0.2069
2019-11-14 2019-09-30 13F AMGEN COM 031162100 5,728 2,487 76.74 1,108 85.28 0.2102
2019-08-14 2019-06-30 13F AMGEN COM 031162100 3,241 -144 -4.25 598 -7.00 0.1268
2019-05-15 2019-03-31 13F AMGEN COM 031162100 3,385 69 2.08 643 -0.31 0.1365
2019-02-14 2018-12-31 13F AMGEN COM 031162100 3,316 -169 -4.85 645 -10.66 0.1601
2018-11-14 2018-09-30 13F AMGEN COM 031162100 3,485 95 2.80 722 15.52 0.1515
2018-08-14 2018-06-30 13F AMGEN COM 031162100 3,390 548 19.28 625 29.13 0.1324
2018-05-15 2018-03-31 13F AMGEN COM 031162100 2,842 -574 -16.80 484 -18.52 0.0846
2018-02-14 2017-12-31 13F AMGEN COM 031162100 3,416 673 24.54 594 16.02 0.1339
2017-11-14 2017-09-30 13F AMGEN COM 031162100 2,743 -117 -4.09 512 3.85 0.1551
2017-08-14 2017-06-30 13F AMGEN COM 031162100 2,860 -14 -0.49 493 4.45 0.1447
2017-05-15 2017-03-31 13F AMGEN COM 031162100 2,874 -15 -0.52 472 11.85 0.1420
2017-02-14 2016-12-31 13F AMGEN COM 031162100 2,889 -7 -0.24 422 -12.63 0.1322
2016-11-14 2016-09-30 13F AMGEN COM 031162100 2,896 -15 -0.52 483 9.03 0.1520
2016-08-15 2016-06-30 13F AMGEN COM 031162100 2,911 99 3.52 443 4.98 0.1408
2016-05-16 2016-03-31 13F AMGEN COM 031162100 2,812 -382 -11.96 422 -18.53 0.1321
2016-02-16 2015-12-31 13F AMGEN COM 031162100 3,194 -12 -0.37 518 16.67 0.1506
2015-11-16 2015-09-30 13F AMGEN COM 031162100 3,206 101 3.25 444 -6.92 0.1298
2015-08-14 2015-06-30 13F AMGEN COM 031162100 3,105 432 16.16 477 11.45 0.1298
2015-05-15 2015-03-31 13F AMGEN COM 031162100 2,673 2,673 428 0.1094
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.